Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Profit After Tax: 2016-2019

Historic Profit After Tax for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to -$4.2 million.

  • Monopar Therapeutics' Profit After Tax fell 35.53% to -$1.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$4.2 million, marking a year-over-year decrease of 38.65%. This contributed to the annual value of -$4.2 million for FY2019, which is 30.88% down from last year.
  • Monopar Therapeutics' Profit After Tax amounted to -$4.2 million in FY2019, which was down 30.88% from -$3.2 million recorded in FY2018.
  • Monopar Therapeutics' Profit After Tax's 5-year high stood at -$1.2 million during FY2016, with a 5-year trough of -$16.6 million in FY2017.
  • For the 3-year period, Monopar Therapeutics' Profit After Tax averaged around -$8.0 million, with its median value being -$4.2 million (2019).
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 1,296.33% in 2017, then skyrocketed by 80.50% in 2018.
  • Over the past 4 years, Monopar Therapeutics' Profit After Tax (Yearly) stood at -$1.2 million in 2016, then plummeted by 1,296.33% to -$16.6 million in 2017, then surged by 80.50% to -$3.2 million in 2018, then slumped by 30.88% to -$4.2 million in 2019.